Cargando…

How We Read Oncologic FDG PET/CT

(18)F-fluorodeoxyglucose (FDG) PET/CT is a pivotal imaging modality for cancer imaging, assisting diagnosis, staging of patients with newly diagnosed malignancy, restaging following therapy and surveillance. Interpretation requires integration of the metabolic and anatomic findings provided by the P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hofman, Michael S., Hicks, Rodney J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067887/ https://www.ncbi.nlm.nih.gov/pubmed/27756360 http://dx.doi.org/10.1186/s40644-016-0091-3

Ejemplares similares

How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology
por: Lasocki, Arian, et al.
Publicado: (2019)

How we read FCH-PET/CT for prostate cancer
por: Beauregard, Jean-Mathieu, et al.
Publicado: (2016)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

White fat, factitious hyperglycemia, and the role of FDG PET to enhance understanding of adipocyte metabolism
por: Hofman, Michael S, et al.
Publicado: (2011)

Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2012)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

Appropriateness criteria of FDG PET/CT in oncology
por: Agrawal, Archi, et al.
Publicado: (2015)

How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting
por: Colleran, Gabrielle C., et al.
Publicado: (2017)

FDG-PET/CT pitfalls in oncological head and neck imaging
por: Purohit, Bela S., et al.
Publicado: (2014)

Integrated (18)FDG PET/CT: Utility and Applications in Clinical Oncology
por: Pinilla, Inmaculada, et al.
Publicado: (2008)

Non-FDG PET/CT in Diagnostic Oncology: a pictorial review
por: Giammarile, Francesco, et al.
Publicado: (2019)

(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity
por: Chang, Chian A., et al.
Publicado: (2016)

Growing applications of FDG PET-CT imaging in non-oncologic conditions
por: Zhuang, Hongming, et al.
Publicado: (2015)

PET/CT: will it change the way that we use CT in cancer imaging?
por: Hicks, Rodney J, et al.
Publicado: (2006)

FDG-PET/CT pitfalls in gynecological and genitourinary oncological imaging
por: Lakhani, A, et al.
Publicado: (2015)

Beyond FDG: novel PET tracers for cancer imaging
por: Hicks, Rodney J
Publicado: (2003)

Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients
por: Quak, Elske, et al.
Publicado: (2015)

Quantitative FDG PET Assessment for Oncology Therapy
por: Hirata, Kenji, et al.
Publicado: (2021)

FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature
por: Aide, Nicolas, et al.
Publicado: (2018)

The role of (18)F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!
por: Hung, Te-Jui, et al.
Publicado: (2019)

What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours
por: Blautzik, Janusch, et al.
Publicado: (2019)

FDG PET/CT of COVID-19
por: Zou, Sijuan, et al.
Publicado: (2020)

The impact of infection and inflammation in oncologic (18)F-FDG PET/CT imaging
por: Rahman, W. Tania, et al.
Publicado: (2019)

Overview of early response assessment in lymphoma with FDG-PET
por: MacManus, Michael P, et al.
Publicado: (2007)

FDG-PET/CT in Lymphoma: Where Do We Go Now?
por: Al Tabaa, Yassine, et al.
Publicado: (2021)

Can the Efficacy of [(18)F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles?
por: O’Neill, Hazel, et al.
Publicado: (2019)

Methodological considerations in quantification of oncological FDG PET studies
por: Vriens, Dennis, et al.
Publicado: (2009)

The role of FDG-PET/CT in gynaecological cancers
por: Rockall, Andrea G, et al.
Publicado: (2012)

The utility of (18) F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification
por: Cochet, Alexandre, et al.
Publicado: (2014)

Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CT
por: Pattison, David A., et al.
Publicado: (2019)

Seventy FDG-PET/CT Cases in Which Nuclear Medicine Physicians Suspected Lymphoma: How Reliable Are We?
por: Toriihara, Akira, et al.
Publicado: (2017)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

FDG PET/CT in carcinoma of unknown primary
por: Kwee, Thomas C., et al.
Publicado: (2009)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

In Which Patients with Sarcoidosis Is FDG PET/CT Indicated?
por: Keijsers, Ruth G.M., et al.
Publicado: (2020)

So, you want to get into “total-body” PET/CT scanning? An installation guide for beginners!
por: Hicks, Rodney J.
Publicado: (2023)

PET-CT imaging in pediatric oncology
por: McCarville, M. Beth
Publicado: (2009)

The Impact of PET/CT on Paediatric Oncology
por: Brink, Anita, et al.
Publicado: (2023)

Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer
por: Al-Ibraheem, Akram, et al.
Publicado: (2009)

PET/CT variants and pitfalls in malignant melanoma
por: Aide, Nicolas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jd86t2c22mvo8ij8a3qcmqnc5a